Approval for TECVAYLITM, a subcutaneously administered therapy, is based on results from the Phase 1/2 MajesTEC-1 study that showed deep and durable responses in triple-class exposed patients with relapsed or… Read More
First NHS pilot of nasal photodisinfection for the prevention of post-surgical infections starts at Mid Yorkshire Teaching NHS Trust The pilot will assess the effect of nasal photodisinfection on 500… Read More
Areas of progress include rare skin diseases, cardio-renal-metabolic diseases, and immuno-oncology Jardiance® and NexGard® portfolios drive strong growth First half 2023 net sales up 9.7 percent at 12.2 billion EUR… Read More
SnapCyte Solutions Inc. Announces the Launch of their First Products VANCOUVER, BC — Public Announcement — SnapCyte Solutions Inc., a bio-analytical software company committed to advancing artificial intelligence (AI)-powered smartphone… Read More
This is the third year that Pfizer Canada and Rethink join forces to prioritize the voices and quality of life of people living with mBC KIRKLAND, QC — Rethink Breast… Read More
